NY-WEA
11.1.2022 13:09:07 CET | Business Wire | Press release
The Women’s Entrepreneurship Accelerator (WEA), today announced the global launch of its online entrepreneurship curriculum designed to inspire, educate, and empower women entrepreneurs around the world. The Online Entrepreneurship Certificate Programme was first announced during the United Nations General Assembly (UNGA 76) on the second anniversary of WEA.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220111005443/en/
WEA is a multi-stakeholder strategic partnership convening six United Nations agencies: International Labour Organization (ILO), International Trade Centre (ITC), International Telecommunication Union (ITU), United Nations Development Programme (UNDP), United Nations Global Compact (UNGC), UN Women, and Mary Kay. ITC is leading the capacity-building component of the multi-partnership.
Developed by ITC SheTrades and powered by Mary Kay in support of WEA, the guided Entrepreneurship Certificate Programme includes 27 interactive modules enriched with over 200 videos. The aim is to teach women entrepreneurs—aspiring or veteran—the skills to design and set up businesses that have potential to be economically viable. Participants will learn how to adopt an entrepreneurship culture, develop ideas through design thinking and lean start-up methodologies, prepare a business model canvas, design a pitch, identify sources of funding, find the right partners, arrange for mentorship, build a team, and set up their businesses.
The Certificate Programme covers the seven key stages of business development :
- Certificate 1: Deciding to Become an Entrepreneur (6 modules),
- Certificate 2: Developing the Idea – Business Ideation (3 modules),
- Certificate 3: Business Modelling (4 modules),
- Certificate 4: Pitching the Business (4 modules),
- Certificate 5: Funding the Venture (3 modules),
- Certificate 6: Building up the Team (4 modules),
- Certificate 7: Setting up the Business (3 modules).
The WEA Online Entrepreneurship Certificate Programme is now accessible at the fingertips of millions of women directly on the ITC SheTrades website (www.shetrades.com/en/learn/e-learning ) and on the WEA website. It is currently available in English, Spanish, and French, with Arabic, Russian and Mandarin coming in 2022. It is free for all users of shetrades.com with no barrier to entry. Participants will receive a certificate upon completion of each of the seven key stages of business development .
“The world needs more women entrepreneurs,” said Deborah Gibbins, Chief Operating Officer at Mary Kay Inc . “Almost half of all women entrepreneurs claim to be driven by the desire to contribute to the great societal good. Their impact can be immense. The WEA Online Entrepreneurship Certificate Programme is a game-changer for women and girls around the world. With the right tools and support, there’s no limit to what women can do.”
“We must increase women’s participation in international trade, helping them scale their businesses so that they become the catalysts for more inclusive and sustainable communities. Women are powerful agents of change – and empowering women benefits whole societies,” said Pamela Coke-Hamilton, Executive Director of the International Trade Centre .
An official launch event will be held on January 18, 2022, at 15:00 CET in collaboration with Mary Kay. It will convene women entrepreneurs and women-owned businesses from the ITC SheTrades network around the world. The event will be hosted virtually in English and will serve as a platform to present the Entrepreneurship Certificate Programme, and upcoming in-country trainings. The SheTrades team will present the entrepreneurship curriculum as well as other tools available on www.shetrades.com . Register here to the launch of WEA’s first free Entrepreneurship Certificate Programme.
The launch of the WEA Certificate Programme on the ITC SheTrades eLearning platform will also be supplemented at the national level with on-the-ground training for women from developing countries interested in entrepreneurship and/or planning to integrate into regional and global value chains. The in-country training sessions will provide practical insight and expertise to women entrepreneurs and MSMEs and will take place virtually in Colombia, Brazil, Mexico and India. The training sessions will be held in Spanish (Colombia, Mexico), Portuguese (Brasil) and English (India). Sessions will focus on two main topics: “Competitiveness and Export Readiness” (19-20 January) and “Digital Marketing and e-commerce workshops” (1-3 February).
The contribution falls under ITC's “Empowering Women to Trade Programme” which contributes directly to ITC’s focus area 5 “Promoting and Mainstreaming Inclusive and Green Trade” and United Nations Sustainable Development Goals (SDGs) 5, 8 and 17.
WEA has committed to empower 5 million women entrepreneurs by 2030.
About the Women’s Entrepreneurship Accelerator
The Women’s Entrepreneurship Accelerator (WEA) is a multi-partnership initiative on women’s entrepreneurship convening six United Nations agencies and Mary Kay. International Labour Organization (ILO), International Trade Centre (ITC), International Telecommunication Union (ITU), UN Development Programme (UNDP), UN Global Compact (UNGC), UN Women and Mary Kay have committed to empower 5 million women entrepreneurs by 2030. The ultimate goal of the initiative is to maximize the development impact of women entrepreneurship in achieving the Sustainable Development Goals (SDGs) by creating an enabling ecosystem for women entrepreneurs around the world. The Accelerator exemplifies the transformational power of a multi-partnership of unique magnitude to harness the potential of women entrepreneurs. Learn more at we-accelerate.com
. Follow us: Twitter and Instagram (@we_accelerator), Facebook and LinkedIn (@womensentrepreneurshipaccelerator).
About ITC SheTrades
The International Trade Centre’s SheTrades initiative aims to connect three million women to market by 2021 and rallies stakeholders around the world to work together to address trade barriers and create greater opportunities for women entrepreneurs. It is supported by a web and mobile digital platform. For more information, please visit SheTrades.com: https://www.shetrades.com/en
.
About the International Trade Centre
The International Trade Centre is the joint agency of the World Trade Organization and the United Nations. ITC assists small and medium-sized enterprises in developing and transition economies to become more competitive in global markets, thereby contributing to sustainable economic development within the frameworks of the Aid-for-Trade agenda and the United Nations’ Sustainable Development Goals. For more information, visit www.intracen.org
. Follow ITC on Twitter
| Facebook
| LinkedIn
| Instagram
| Flickr
View source version on businesswire.com: https://www.businesswire.com/news/home/20220111005443/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom